atherosclerosis, cardiovascular disease, primary prevention, normal cholesterol, elevated C-reactive protein
DISEASE INTERVENTION COMPARISON RESULTS
N Engl J Med. 2008 Nov 20;359(21):2195-207 Randomized Controlled Trial, Multicenter Study
IN atherosclerosis, cardiovascular disease, primary prevention, normal cholesterol, elevated C-reactive protein The Use of
statins, rosuvastatin
As Prevention, Primary
Is better Than
placebo
To reduce the incidence of major cardiovascular events at 2 years: 0.77% per year statin VS 1.4% per year placebo.